The re-evaluation of a central nervous system stimulant: pipradrol hydrochloride.
D000275:Adjustment Disorders / Q000188:drug therapy*; D000328:Adult; D000368:Aged; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010880:Piperidines / Q000009:adverse effects / Q000627:therapeutic use*; D010919:Placebos; D011569:Psychiatric Status Rating Scales; D013997:Time Factors
D010880:Piperidines; D010919:Placebos